Answer
Kymriah (tisagenlecleucel) dispersion for infusion must be stored and transported at ≤ −120°C and remain frozen until the patient is ready for treatment; it must not be refrozen after thawing.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §6.4 Special precautions for storage · Version 15Document updated
Sources checked